The correlation between tumor size, lymph node status, distant metastases and mortality in rectal cancer patients without neoadjuvant therapy

Luo, Dakui; Shan, Zezhi; Liu, Qi; Cai, Sanjun; Ma, Yanlei; Li, Qingguo; Li, Xinxiang

doi:10.7150/jca.52165



International Journal of Biological Sciences

International Journal of Medical Sciences

Theranostics

Journal of Genomics

Nanotheranostics

Global reach, higher impact

Full Text | PDF

J Cancer 2021; 12(6):1616-1622. doi:10.7150/jca.52165 This issue Cite

Research Paper

The correlation between tumor size, lymph node status, distant metastases and mortality in rectal cancer patients without neoadjuvant therapy

Dakui Luo^1,2#, Zezhi Shan^1,2#, Qi Liu^1,2#, Sanjun Cai^1,2, Yanlei Ma^1,2, Qingguo Li^1,2✉, Xinxiang Li^1,2✉

1. Department of Colorectal Surgery, Fudan University Shanghai Cancer Center, Shanghai 200032, China.
2. Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China.
# Equal contributions

Citation:

Luo D, Shan Z, Liu Q, Cai S, Ma Y, Li Q, Li X. The correlation between tumor size, lymph node status, distant metastases and mortality in rectal cancer patients without neoadjuvant therapy. J Cancer 2021; 12(6):1616-1622. doi:10.7150/jca.52165. https://www.jcancer.org/v12p1616.htm

Other styles

Abstract

Tumor size has an effect on decision making for the treatment rectal cancer. Transanal local excision can be selected to remove rectal cancer with favorable histopathological features. It is generally recognized that the risk of lymph node involvement and distant metastases increases as the tumor enlarges. However, the majority of the studies classified patients into two groups using concrete value as a cutoff point. The coarse classification was not sufficient to reveal a correlation between the tumor size and lymph node status or distant metastases across the full range of sizes examined. Between 1988 and 2015, a total of 77,746 patients were diagnosed with first primary rectal cancer who had not received neoadjuvant therapy. These subjects were identified using the Surveillance, Epidemiology and End Results (SEER) database. The association between tumor size, lymph node status, distant metastases and cancer-specific mortality was investigated. Tumor size was examined as a continuous (1-30 mm) and categorical variable (11 size groups; 10-mm intervals). A non-linear correlation between increasing tumor size and the prevalence of lymph node involvement was observed, while a near-positive correlation between tumor size and distant metastases was presented. In addition, the 5-year and 10-year rates of rectal cancer-specific mortality were increased as the tumor enlarged. For small tumors (under 30 mm), a positive correlation was noted between tumor size and lymph node involvement. The clinical value of the tumor size should be reevaluated by exact classification.

Keywords: tumor size, lymph node status, distant metastases, rectal cancer, SEER

Citation styles

APA

Luo, D., Shan, Z., Liu, Q., Cai, S., Ma, Y., Li, Q., Li, X. (2021). The correlation between tumor size, lymph node status, distant metastases and mortality in rectal cancer patients without neoadjuvant therapy. Journal of Cancer, 12(6), 1616-1622. https://doi.org/10.7150/jca.52165.

ACS

Luo, D.; Shan, Z.; Liu, Q.; Cai, S.; Ma, Y.; Li, Q.; Li, X. The correlation between tumor size, lymph node status, distant metastases and mortality in rectal cancer patients without neoadjuvant therapy. J. Cancer 2021, 12 (6), 1616-1622. DOI: 10.7150/jca.52165.

NLM

CSE

Luo D, Shan Z, Liu Q, Cai S, Ma Y, Li Q, Li X. 2021. The correlation between tumor size, lymph node status, distant metastases and mortality in rectal cancer patients without neoadjuvant therapy. J Cancer. 12(6):1616-1622.

This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.